1. Paraoxonase 2 Facilitates Pancreatic Cancer Growth and Metastasis by Stimulating GLUT1-Mediated Glucose Transport
    Arvindhan Nagarajan et al, 2017, Molecular Cell CrossRef
  2. Glucose metabolic phenotype of pancreatic cancer
    Anthony KC Chan et al, 2016, WJG CrossRef
  3. GPR55 receptor antagonist decreases glycolytic activity in PANC-1 pancreatic cancer cell line and tumor xenografts
    Michel Bernier et al, 2017, Int. J. Cancer CrossRef
  4. Metabolism in cancer metastasis: bioenergetics, biosynthesis, and beyond.
    Shao Thing Teoh et al, 2018, Wiley Interdiscip Rev Syst Biol Med CrossRef
  5. Pyruvate kinase M2 promotes pancreatic ductal adenocarcinoma invasion and metastasis through phosphorylation and stabilization of PAK2 protein
    Tsu-Yao Cheng et al, 2018, Oncogene CrossRef
  6. Glycolysis-related protein expression in thyroid cancer
    Ji Hae Nahm et al, 2017, Tumour Biol. CrossRef
  7. Pyruvate kinase M2 fuels multiple aspects of cancer cells: from cellular metabolism, transcriptional regulation to extracellular signaling
    Ming-Chuan Hsu et al, 2018, Mol Cancer CrossRef
  8. Evaluation of tumor M2-pyruvate kinase (Tumor M2-PK) as a biomarker for pancreatic cancer
    Indika A. Bandara et al, 2018, World J Surg Onc CrossRef
  9. Pyruvate Kinase Isozyme M2 Plays a Critical Role in the Interactions Between Pancreatic Stellate Cells and Cancer Cells
    Atsushi Masamune et al, 2018, Dig Dis Sci CrossRef
  10. PKM2 is not required for pancreatic ductal adenocarcinoma
    Alissandra L Hillis et al, 2018, Cancer Metab CrossRef
  11. KiSS1 in regulation of metastasis and response to antitumor drugs
    Cristina Corno et al, 2019, Drug Resistance Updates CrossRef
  12. Prognostic role of glycolysis for cancer outcome: evidence from 86 studies
    Min Yu et al, 2019, J Cancer Res Clin Oncol CrossRef
  13. The peculiarities of cancer cell metabolism: A route to metastasization and a target for therapy
    Tiago MA. Carvalho et al, 2019, European Journal of Medicinal Chemistry CrossRef
  14. The CIMP-high phenotype is associated with energy metabolism alterations in colon adenocarcinoma
    Maria S. Fedorova et al, 2019, BMC Med Genet CrossRef
  15. The Warburg Effect Is Associated With Tumor Aggressiveness in Testicular Germ Cell Tumors
    Murilo Bonatelli et al, 2019, Front. Endocrinol. CrossRef
  16. Prognostic Significance of the Metabolic Marker Hexokinase-2 in Various Solid Tumors: A Meta-Analysis
    Yulin Liu et al, 2016, PLoS ONE CrossRef
  17. Effect of lentivirus-mediated shRNA inactivation of HK1, HK2, and HK3 genes in colorectal cancer and melanoma cells
    Anna V. Kudryavtseva et al, 2016, BMC Genet CrossRef
  18. Metabolic Regulation of Epithelial to Mesenchymal Transition: Implications for Endocrine Cancer
    Debasmita Bhattacharya et al, 2019, Front. Endocrinol. CrossRef
  19. Cysteine catabolism and the serine biosynthesis pathway support pyruvate production during pyruvate kinase knockdown in pancreatic cancer cells
    Lei Yu et al, 2019, Cancer Metab CrossRef
  20. Delineation of hypoxia-induced proteome shifts in osteosarcoma cells with different metastatic propensities
    Zifeng Song et al, 2020, Sci Rep CrossRef
  21. Metabolic reprogramming and disease progression in cancer patients.
    Laura Torresano et al, 2020, Biochim Biophys Acta Mol Basis Dis CrossRef
  22. Regulatory Role of Hexokinase 2 in Modulating Head and Neck Tumorigenesis
    Wan-Chun Li et al, 2020, Front. Oncol. CrossRef
  23. Poor prognosis of hexokinase 2 overexpression in solid tumors of digestive system: a meta-analysis
    Jiayuan Wu et al, 2017, Oncotarget CrossRef
  24. Pyruvate kinase M2 (PKM2) expression correlates with prognosis in solid cancers: a meta-analysis.
    Haiyan Zhu et al, 2017, Oncotarget CrossRef
  25. Hexokinase 2 promotes tumor growth and metastasis by regulating lactate production in pancreatic cancer
    Marybeth Anderson et al, 2017, Oncotarget CrossRef
  26. Metformin alleviates nickel-induced autophagy and apoptosis via inhibition of hexokinase-2, activating lipocalin-2, in human bronchial epithelial cells
    Yu-Ting Kang et al, 2017, Oncotarget CrossRef
  27. Platinum-based drugs in neoadjuvant treatment of patients with triple-negative breast cancer
    E.A. Nikitina et al, 2020, Onkol. Z. im. P.A. Gercena CrossRef
  28. Capsaicin inhibits glycolysis in esophageal squamous cell carcinoma by regulating hexokinase‑2 expression
    Xinli Mao et al, 2018, Mol Med Report CrossRef
  29. Effect of HK2, PKM2 and LDHA on Cetuximab efficacy in metastatic colorectal cancer
    Haohua Wang et al, 2018, Oncol Lett CrossRef
  30. Correlation of exosomal microRNA clusters with bone metastasis in non-small cell lung cancer
    Xiao-Rong Yang et al, 2020, Clin Exp Metastasis CrossRef
  31. Glucose Metabolism Reprogrammed by Overexpression of IKKε Promotes Pancreatic Tumor Growth
    Haseeb Zubair et al, 2016, Cancer Res CrossRef
  32. LPA Induces Metabolic Reprogramming in Ovarian Cancer via a Pseudohypoxic Response.
    Ji Hee Ha et al, 2018, Cancer Res CrossRef
  33. TKP, a Serine Protease from Trichosanthes kirilowii, Inhibits Cell Proliferation by Blocking Aerobic Glycolysis in Hepatocellular Carcinoma Cells
    Hong Zhao et al, 2021, Nutrition and Cancer CrossRef
  34. The Glycolytic Pathway as a Target for Novel Onco-Immunology Therapies in Pancreatic Cancer
    Claudia Curcio et al, 2021, Molecules CrossRef
  35. Potassium ions promote hexokinase-II dependent glycolysis
    Helmut Bischof et al, 2021, iScience CrossRef
  36. null
    Atul Kumar et al, 2021 CrossRef
  37. Molecular and Metabolic Reprogramming: Pulling the Strings Toward Tumor Metastasis
    Ana Hipólito et al, 2021, Front. Oncol. CrossRef
  38. Targeting Glycolysis in Macrophages Confers Protection Against Pancreatic Ductal Adenocarcinoma
    Hweixian Leong Penny et al, 2021, IJMS CrossRef
  39. Therapeutic resistance in pancreatic ductal adenocarcinoma: Current challenges and future opportunities
    Aditi Jain et al, 2021, WJG CrossRef
  40. Immunometabolism at the service of traditional Chinese medicine
    He-Rong Cui et al, 2022, Pharmacological Research CrossRef
  41. Expression of HK2, PKM2, and PFKM Is Associated with Metastasis and Late Disease Onset in Breast Cancer Patients
    Mehreen Ishfaq et al, 2022, Genes CrossRef
  42. Prognostic value of glycolysis markers in pancreatic cancer: A systematic review and meta-analysis
    Chengcheng Wang et al, 2022, Front. Oncol. CrossRef
  43. Upregulated Apelin Signaling in Pancreatic Cancer Activates Oncogenic Signaling Pathways to Promote Tumor Development
    Carline Chaves-Almagro et al, 2022, IJMS CrossRef
  44. Modulation of Ca2+ signaling by antiapoptotic Bcl-2 versus Bcl-xL: From molecular mechanisms to relevance for cancer cell survival
    Nicolas Rosa et al, 2022, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef